| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 30 | 2022 | 134 | 4.430 |
Why?
|
| Intestinal Mucosa | 27 | 2020 | 220 | 3.450 |
Why?
|
| Circadian Rhythm | 17 | 2022 | 281 | 2.140 |
Why?
|
| Intestines | 17 | 2022 | 107 | 2.100 |
Why?
|
| Alcoholism | 8 | 2022 | 83 | 1.900 |
Why?
|
| Colon | 15 | 2023 | 148 | 1.900 |
Why?
|
| Liver Diseases, Alcoholic | 8 | 2017 | 45 | 1.660 |
Why?
|
| Gastrointestinal Microbiome | 12 | 2023 | 181 | 1.530 |
Why?
|
| Permeability | 20 | 2021 | 134 | 1.340 |
Why?
|
| Oxidative Stress | 10 | 2017 | 124 | 1.230 |
Why?
|
| Epithelial Cells | 9 | 2022 | 88 | 1.150 |
Why?
|
| Animals | 45 | 2023 | 4577 | 1.120 |
Why?
|
| Cytochrome P-450 CYP2E1 | 3 | 2014 | 13 | 1.100 |
Why?
|
| Central Nervous System Depressants | 6 | 2019 | 24 | 1.020 |
Why?
|
| CLOCK Proteins | 7 | 2018 | 26 | 0.940 |
Why?
|
| Alcohol Drinking | 7 | 2020 | 78 | 0.900 |
Why?
|
| Mice | 23 | 2023 | 1620 | 0.880 |
Why?
|
| Inflammation | 11 | 2021 | 345 | 0.860 |
Why?
|
| Liver | 5 | 2017 | 173 | 0.840 |
Why?
|
| Parkinson Disease | 7 | 2023 | 1164 | 0.800 |
Why?
|
| Circadian Clocks | 5 | 2022 | 32 | 0.780 |
Why?
|
| Stem Cells | 2 | 2017 | 46 | 0.760 |
Why?
|
| Microbiota | 7 | 2023 | 105 | 0.750 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 200 | 0.720 |
Why?
|
| Transcription Factors | 2 | 2011 | 157 | 0.700 |
Why?
|
| Period Circadian Proteins | 5 | 2021 | 23 | 0.690 |
Why?
|
| Mice, Inbred C57BL | 16 | 2023 | 432 | 0.680 |
Why?
|
| Feces | 10 | 2023 | 98 | 0.670 |
Why?
|
| Dysbiosis | 8 | 2022 | 64 | 0.660 |
Why?
|
| Male | 41 | 2022 | 15637 | 0.650 |
Why?
|
| Humans | 62 | 2023 | 29361 | 0.640 |
Why?
|
| Organoids | 1 | 2017 | 8 | 0.630 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 3 | 2019 | 10 | 0.590 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2015 | 64 | 0.590 |
Why?
|
| Endotoxemia | 7 | 2015 | 29 | 0.580 |
Why?
|
| Disease Models, Animal | 11 | 2023 | 726 | 0.570 |
Why?
|
| Bacterial Translocation | 2 | 2015 | 33 | 0.540 |
Why?
|
| Intestinal Absorption | 6 | 2017 | 42 | 0.520 |
Why?
|
| Gastrointestinal Tract | 5 | 2023 | 55 | 0.500 |
Why?
|
| alpha-Synuclein | 2 | 2015 | 138 | 0.480 |
Why?
|
| Fatty Acids, Volatile | 4 | 2023 | 30 | 0.480 |
Why?
|
| Fatty Liver | 4 | 2018 | 30 | 0.470 |
Why?
|
| Colonic Neoplasms | 2 | 2013 | 66 | 0.460 |
Why?
|
| Caco-2 Cells | 9 | 2015 | 53 | 0.450 |
Why?
|
| Gastrointestinal Diseases | 3 | 2019 | 43 | 0.450 |
Why?
|
| Cartilage, Articular | 4 | 2015 | 524 | 0.440 |
Why?
|
| Endotoxins | 1 | 2011 | 24 | 0.420 |
Why?
|
| Digestive System | 1 | 2010 | 16 | 0.380 |
Why?
|
| Probiotics | 2 | 2015 | 20 | 0.370 |
Why?
|
| Chondrocytes | 3 | 2008 | 197 | 0.360 |
Why?
|
| Mesoderm | 1 | 2009 | 19 | 0.360 |
Why?
|
| Photoperiod | 4 | 2021 | 43 | 0.360 |
Why?
|
| MicroRNAs | 4 | 2015 | 42 | 0.350 |
Why?
|
| Aspirin | 1 | 2010 | 83 | 0.350 |
Why?
|
| Multiple System Atrophy | 2 | 2022 | 42 | 0.350 |
Why?
|
| ErbB Receptors | 1 | 2009 | 72 | 0.350 |
Why?
|
| Cell Membrane Permeability | 4 | 2015 | 56 | 0.340 |
Why?
|
| Neurons | 1 | 2011 | 374 | 0.330 |
Why?
|
| Collagenases | 2 | 2005 | 20 | 0.330 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 175 | 0.320 |
Why?
|
| Carrier Proteins | 3 | 2021 | 97 | 0.320 |
Why?
|
| Membrane Glycoproteins | 3 | 2021 | 101 | 0.320 |
Why?
|
| Work Schedule Tolerance | 2 | 2020 | 39 | 0.320 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 284 | 0.310 |
Why?
|
| Fatty Liver, Alcoholic | 3 | 2014 | 11 | 0.300 |
Why?
|
| Immunity, Mucosal | 3 | 2019 | 29 | 0.300 |
Why?
|
| Neurosecretory Systems | 2 | 2022 | 9 | 0.300 |
Why?
|
| Middle Aged | 17 | 2021 | 9823 | 0.290 |
Why?
|
| Macrophage-1 Antigen | 2 | 2007 | 10 | 0.290 |
Why?
|
| Intestine, Small | 2 | 2017 | 33 | 0.290 |
Why?
|
| Candida albicans | 2 | 2007 | 22 | 0.280 |
Why?
|
| Colon, Sigmoid | 2 | 2017 | 18 | 0.280 |
Why?
|
| Female | 20 | 2021 | 16211 | 0.280 |
Why?
|
| Signal Transduction | 6 | 2019 | 483 | 0.280 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 329 | 0.280 |
Why?
|
| Colitis | 2 | 2023 | 37 | 0.270 |
Why?
|
| Chronobiology Disorders | 2 | 2017 | 14 | 0.270 |
Why?
|
| Rats | 9 | 2020 | 858 | 0.260 |
Why?
|
| Molecular Targeted Therapy | 2 | 2018 | 32 | 0.250 |
Why?
|
| Metabolome | 2 | 2015 | 16 | 0.250 |
Why?
|
| Volatile Organic Compounds | 2 | 2015 | 10 | 0.250 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2011 | 89 | 0.250 |
Why?
|
| HIV Infections | 3 | 2018 | 980 | 0.240 |
Why?
|
| Feeding Behavior | 3 | 2019 | 100 | 0.240 |
Why?
|
| Aging | 3 | 2018 | 1594 | 0.230 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 10 | 0.230 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 41 | 0.230 |
Why?
|
| Sucrose | 3 | 2011 | 17 | 0.230 |
Why?
|
| Osteoarthritis | 3 | 2018 | 363 | 0.220 |
Why?
|
| Mice, Knockout | 4 | 2022 | 304 | 0.220 |
Why?
|
| Biomarkers | 5 | 2021 | 692 | 0.220 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 11 | 0.220 |
Why?
|
| Propionates | 1 | 2022 | 12 | 0.210 |
Why?
|
| CD18 Antigens | 1 | 2002 | 6 | 0.210 |
Why?
|
| Osteogenesis | 1 | 2022 | 99 | 0.210 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2018 | 33 | 0.200 |
Why?
|
| Lymphocytes | 1 | 2002 | 110 | 0.200 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2019 | 26 | 0.200 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2021 | 6 | 0.200 |
Why?
|
| Veterans | 1 | 2022 | 63 | 0.200 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 87 | 0.190 |
Why?
|
| Adult | 13 | 2020 | 8604 | 0.190 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2021 | 39 | 0.190 |
Why?
|
| Osteoarthritis, Knee | 2 | 2015 | 381 | 0.190 |
Why?
|
| Snail Family Transcription Factors | 2 | 2011 | 5 | 0.190 |
Why?
|
| Carcinogenesis | 2 | 2019 | 21 | 0.190 |
Why?
|
| Immunity, Innate | 1 | 2021 | 90 | 0.190 |
Why?
|
| Acute-Phase Proteins | 3 | 2021 | 14 | 0.190 |
Why?
|
| Occludin | 2 | 2017 | 13 | 0.180 |
Why?
|
| Carbohydrates | 2 | 2015 | 14 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2011 | 453 | 0.180 |
Why?
|
| Colonic Polyps | 1 | 2019 | 23 | 0.180 |
Why?
|
| Adipose Tissue | 2 | 2018 | 74 | 0.180 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 189 | 0.180 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2019 | 4 | 0.180 |
Why?
|
| Time Factors | 7 | 2019 | 1618 | 0.180 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2014 | 97 | 0.170 |
Why?
|
| Osteolysis | 1 | 2020 | 150 | 0.170 |
Why?
|
| Rotenone | 1 | 2018 | 10 | 0.170 |
Why?
|
| Tight Junctions | 6 | 2021 | 28 | 0.170 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 167 | 0.170 |
Why?
|
| Diet, High-Fat | 2 | 2015 | 17 | 0.170 |
Why?
|
| Cell Line, Tumor | 4 | 2014 | 265 | 0.160 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2018 | 7 | 0.160 |
Why?
|
| Aged | 9 | 2021 | 9447 | 0.160 |
Why?
|
| Transcription Factor HES-1 | 1 | 2017 | 5 | 0.160 |
Why?
|
| Keratin-20 | 1 | 2017 | 5 | 0.160 |
Why?
|
| Jejunum | 1 | 2017 | 10 | 0.160 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 33 | 0.160 |
Why?
|
| Chromogranin A | 1 | 2017 | 13 | 0.160 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 7 | 0.160 |
Why?
|
| Hypercholesterolemia | 1 | 2018 | 29 | 0.160 |
Why?
|
| Cadherins | 1 | 2017 | 31 | 0.160 |
Why?
|
| Cell Lineage | 1 | 2017 | 29 | 0.160 |
Why?
|
| Lipopolysaccharides | 2 | 2016 | 127 | 0.160 |
Why?
|
| Binge Drinking | 1 | 2017 | 10 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2017 | 38 | 0.160 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 27 | 0.160 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2016 | 57 | 0.150 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 215 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2018 | 125 | 0.150 |
Why?
|
| Melatonin | 2 | 2016 | 94 | 0.150 |
Why?
|
| Butyrates | 3 | 2022 | 19 | 0.150 |
Why?
|
| Knee Joint | 3 | 2015 | 797 | 0.150 |
Why?
|
| Methamphetamine | 1 | 2018 | 48 | 0.150 |
Why?
|
| Case-Control Studies | 4 | 2021 | 638 | 0.150 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 9 | 0.150 |
Why?
|
| Analgesics | 1 | 2018 | 108 | 0.150 |
Why?
|
| Mast Cells | 2 | 2016 | 26 | 0.150 |
Why?
|
| Kidney | 1 | 2018 | 173 | 0.150 |
Why?
|
| Cells, Cultured | 5 | 2017 | 676 | 0.140 |
Why?
|
| Arthralgia | 1 | 2018 | 121 | 0.140 |
Why?
|
| Disease Susceptibility | 2 | 2015 | 80 | 0.140 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2016 | 22 | 0.140 |
Why?
|
| Sleep | 2 | 2016 | 313 | 0.140 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 255 | 0.140 |
Why?
|
| Risk Factors | 1 | 2022 | 2446 | 0.140 |
Why?
|
| Matrix Metalloproteinase 13 | 4 | 2015 | 30 | 0.140 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2016 | 39 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 82 | 0.140 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 8 | 0.130 |
Why?
|
| Chromatography, Gas | 1 | 2015 | 12 | 0.130 |
Why?
|
| Urinalysis | 1 | 2015 | 9 | 0.130 |
Why?
|
| Up-Regulation | 3 | 2011 | 174 | 0.130 |
Why?
|
| Cell Line | 3 | 2011 | 299 | 0.130 |
Why?
|
| Tyrosine | 2 | 2011 | 23 | 0.130 |
Why?
|
| Joints | 1 | 2015 | 97 | 0.130 |
Why?
|
| Fibronectins | 2 | 2005 | 29 | 0.120 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2015 | 52 | 0.120 |
Why?
|
| Toll-Like Receptors | 1 | 2014 | 28 | 0.120 |
Why?
|
| Young Adult | 6 | 2016 | 1935 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 64 | 0.120 |
Why?
|
| HIV-1 | 1 | 2018 | 440 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 153 | 0.120 |
Why?
|
| Solid Phase Microextraction | 1 | 2013 | 4 | 0.120 |
Why?
|
| Oxidants | 2 | 2011 | 28 | 0.120 |
Why?
|
| Artifacts | 1 | 2013 | 32 | 0.120 |
Why?
|
| Specimen Handling | 1 | 2013 | 48 | 0.120 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 57 | 0.120 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2013 | 11 | 0.120 |
Why?
|
| Hippocampus | 1 | 2015 | 274 | 0.110 |
Why?
|
| Alcohol-Related Disorders | 1 | 2013 | 3 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 34 | 0.110 |
Why?
|
| Bacteria | 2 | 2023 | 77 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2013 | 69 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 74 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 250 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2013 | 323 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 40 | 0.100 |
Why?
|
| Escherichia coli Infections | 1 | 2011 | 27 | 0.100 |
Why?
|
| Cell Movement | 2 | 2009 | 105 | 0.100 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 938 | 0.100 |
Why?
|
| Nitric Oxide | 2 | 2009 | 101 | 0.100 |
Why?
|
| Wine | 1 | 2011 | 8 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2011 | 59 | 0.100 |
Why?
|
| Catenins | 1 | 2011 | 1 | 0.100 |
Why?
|
| Diarrhea | 1 | 2011 | 48 | 0.100 |
Why?
|
| Lysine | 1 | 2011 | 13 | 0.100 |
Why?
|
| Crohn Disease | 1 | 2011 | 46 | 0.100 |
Why?
|
| Particulate Matter | 1 | 2011 | 22 | 0.100 |
Why?
|
| p21-Activated Kinases | 1 | 2011 | 11 | 0.100 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 66 | 0.100 |
Why?
|
| Gastric Mucosa | 1 | 2010 | 12 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 441 | 0.090 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2010 | 2 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2009 | 12 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 107 | 0.090 |
Why?
|
| Avena | 1 | 2009 | 5 | 0.090 |
Why?
|
| Colonic Diseases | 1 | 2009 | 12 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 1943 | 0.090 |
Why?
|
| Wound Healing | 1 | 2010 | 168 | 0.080 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2022 | 13 | 0.080 |
Why?
|
| Zonula Occludens-1 Protein | 3 | 2017 | 15 | 0.080 |
Why?
|
| Biopsy | 3 | 2016 | 234 | 0.080 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2008 | 22 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 74 | 0.080 |
Why?
|
| Proteoglycans | 3 | 2015 | 337 | 0.080 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2007 | 4 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2007 | 17 | 0.080 |
Why?
|
| Immunologic Surveillance | 1 | 2007 | 1 | 0.080 |
Why?
|
| Fungal Proteins | 1 | 2007 | 7 | 0.080 |
Why?
|
| Cell Communication | 1 | 2007 | 29 | 0.070 |
Why?
|
| Candidiasis | 1 | 2007 | 17 | 0.070 |
Why?
|
| Leukocytes | 1 | 2007 | 43 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2007 | 43 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2005 | 55 | 0.070 |
Why?
|
| Interleukin-1 | 1 | 2005 | 78 | 0.070 |
Why?
|
| Ankle Joint | 1 | 2005 | 39 | 0.070 |
Why?
|
| Environment | 2 | 2015 | 46 | 0.070 |
Why?
|
| Motor Activity | 2 | 2021 | 369 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 130 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 213 | 0.070 |
Why?
|
| NF-kappa B | 3 | 2011 | 107 | 0.060 |
Why?
|
| Brain | 3 | 2022 | 1687 | 0.060 |
Why?
|
| Dextran Sulfate | 1 | 2023 | 11 | 0.060 |
Why?
|
| Oxygen | 1 | 2023 | 85 | 0.060 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 9 | 0.060 |
Why?
|
| Prebiotics | 1 | 2023 | 16 | 0.060 |
Why?
|
| Ileum | 2 | 2015 | 22 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 1113 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2002 | 11 | 0.050 |
Why?
|
| Laminin | 1 | 2002 | 8 | 0.050 |
Why?
|
| Acetates | 1 | 2022 | 19 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2002 | 19 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2002 | 30 | 0.050 |
Why?
|
| Cell Division | 1 | 2002 | 114 | 0.050 |
Why?
|
| Spleen | 1 | 2002 | 51 | 0.050 |
Why?
|
| Transfection | 1 | 2002 | 125 | 0.050 |
Why?
|
| Cytokines | 2 | 2016 | 348 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 145 | 0.050 |
Why?
|
| Glycomics | 1 | 2021 | 5 | 0.050 |
Why?
|
| Haptoglobins | 1 | 2021 | 5 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 264 | 0.050 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2021 | 15 | 0.050 |
Why?
|
| Luciferases | 1 | 2021 | 24 | 0.050 |
Why?
|
| Metabolomics | 1 | 2021 | 23 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2021 | 19 | 0.050 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2021 | 9 | 0.050 |
Why?
|
| Complement Activation | 1 | 2021 | 13 | 0.050 |
Why?
|
| Receptors, Fc | 1 | 2021 | 11 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2021 | 50 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 17 | 0.050 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 28 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2021 | 55 | 0.050 |
Why?
|
| Glucose | 2 | 2013 | 59 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 27 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 209 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 260 | 0.050 |
Why?
|
| Life Style | 1 | 2022 | 211 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 102 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 2011 | 26 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2011 | 145 | 0.040 |
Why?
|
| DNA Damage | 1 | 2019 | 30 | 0.040 |
Why?
|
| Chronotherapy | 1 | 2019 | 9 | 0.040 |
Why?
|
| Interleukin-1beta | 2 | 2010 | 55 | 0.040 |
Why?
|
| CD3 Complex | 1 | 2018 | 13 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 236 | 0.040 |
Why?
|
| Mutation | 2 | 2015 | 383 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 4851 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2011 | 173 | 0.040 |
Why?
|
| Bone Development | 1 | 2018 | 35 | 0.040 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2018 | 7 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2018 | 12 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2018 | 11 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2018 | 21 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2018 | 48 | 0.040 |
Why?
|
| Cytoskeleton | 2 | 2009 | 51 | 0.040 |
Why?
|
| Models, Biological | 2 | 2011 | 344 | 0.040 |
Why?
|
| Self Administration | 1 | 2018 | 36 | 0.040 |
Why?
|
| Animal Feed | 1 | 2017 | 6 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2017 | 12 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2017 | 13 | 0.040 |
Why?
|
| Hyperalgesia | 1 | 2018 | 46 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 47 | 0.040 |
Why?
|
| Eating | 1 | 2017 | 45 | 0.040 |
Why?
|
| Genotype | 1 | 2018 | 405 | 0.040 |
Why?
|
| Sigmoidoscopy | 1 | 2016 | 8 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 25 | 0.030 |
Why?
|
| Employment | 1 | 2016 | 42 | 0.030 |
Why?
|
| Income | 1 | 2016 | 75 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 83 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 47 | 0.030 |
Why?
|
| Protein Folding | 1 | 2015 | 18 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2016 | 70 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 38 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 1939 | 0.030 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 34 | 0.030 |
Why?
|
| Alkanes | 1 | 2015 | 3 | 0.030 |
Why?
|
| Sesquiterpenes | 1 | 2015 | 4 | 0.030 |
Why?
|
| Terpenes | 1 | 2015 | 4 | 0.030 |
Why?
|
| Body Weight | 1 | 2015 | 133 | 0.030 |
Why?
|
| Fatty Alcohols | 1 | 2015 | 6 | 0.030 |
Why?
|
| Sulfides | 1 | 2015 | 12 | 0.030 |
Why?
|
| Disulfides | 1 | 2015 | 12 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 21 | 0.030 |
Why?
|
| Homeostasis | 1 | 2015 | 82 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 46 | 0.030 |
Why?
|
| Gastrointestinal Absorption | 1 | 2014 | 2 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 329 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 37 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 225 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 7 | 0.030 |
Why?
|
| Educational Status | 1 | 2016 | 295 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2016 | 217 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 37 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 26 | 0.030 |
Why?
|
| Light | 1 | 2014 | 76 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 132 | 0.030 |
Why?
|
| Smoking | 1 | 2015 | 194 | 0.030 |
Why?
|
| Adherens Junctions | 1 | 2013 | 4 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2022 | 3476 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 68 | 0.030 |
Why?
|
| Obesity | 1 | 2015 | 290 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 788 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 146 | 0.030 |
Why?
|
| Cognition | 1 | 2021 | 1279 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2013 | 91 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2015 | 427 | 0.030 |
Why?
|
| Lactulose | 1 | 2011 | 8 | 0.030 |
Why?
|
| Mannitol | 1 | 2011 | 12 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2011 | 8 | 0.030 |
Why?
|
| Immune System | 1 | 2011 | 21 | 0.030 |
Why?
|
| District of Columbia | 1 | 2011 | 5 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2011 | 24 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 15 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2011 | 21 | 0.030 |
Why?
|
| Air Pollution | 1 | 2011 | 17 | 0.030 |
Why?
|
| Cell Death | 1 | 2011 | 61 | 0.030 |
Why?
|
| Particle Size | 1 | 2011 | 78 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 80 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2011 | 43 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 108 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 125 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2011 | 108 | 0.020 |
Why?
|
| Mitochondria | 1 | 2011 | 79 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 126 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2011 | 64 | 0.020 |
Why?
|
| Neutrophils | 1 | 2011 | 117 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2010 | 8 | 0.020 |
Why?
|
| Anastomotic Leak | 1 | 2010 | 5 | 0.020 |
Why?
|
| Antibodies | 1 | 2010 | 65 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 2009 | 6 | 0.020 |
Why?
|
| Protein Carbonylation | 1 | 2009 | 2 | 0.020 |
Why?
|
| Nitrites | 1 | 2009 | 4 | 0.020 |
Why?
|
| Edible Grain | 1 | 2009 | 5 | 0.020 |
Why?
|
| Nitrates | 1 | 2009 | 7 | 0.020 |
Why?
|
| Peroxidase | 1 | 2009 | 18 | 0.020 |
Why?
|
| Actin Cytoskeleton | 1 | 2009 | 13 | 0.020 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2008 | 1 | 0.020 |
Why?
|
| raf Kinases | 1 | 2008 | 1 | 0.020 |
Why?
|
| Metabolism | 1 | 2008 | 9 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 26 | 0.020 |
Why?
|
| Substance P | 1 | 2008 | 18 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 22 | 0.020 |
Why?
|
| Diet | 1 | 2009 | 174 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2007 | 5 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2007 | 112 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2008 | 123 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2007 | 5 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 43 | 0.020 |
Why?
|
| Ligands | 1 | 2007 | 55 | 0.020 |
Why?
|
| Species Specificity | 1 | 2007 | 70 | 0.020 |
Why?
|
| Actins | 1 | 2007 | 45 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 85 | 0.020 |
Why?
|
| Gene Expression | 1 | 2007 | 226 | 0.020 |
Why?
|
| Protein Binding | 1 | 2007 | 127 | 0.020 |
Why?
|
| Cattle | 1 | 2007 | 218 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2008 | 495 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 1184 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 358 | 0.020 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2003 | 1 | 0.010 |
Why?
|
| Integrin alpha5beta1 | 1 | 2003 | 2 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 21 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2003 | 44 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 109 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 99 | 0.010 |
Why?
|